Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions
Abstract Current strategies for active targeting in the brain are entirely based on the effective interaction of the ligand with the orthosteric sites of specific receptors on the blood-brain barrier (BBB), which is highly susceptible to various pathophysiological factors and limits the efficacy of...
Saved in:
| Main Authors: | Kaicheng Tang, Zhongjie Tang, Miaomiao Niu, Zuyin Kuang, Weiwei Xue, Xinyu Wang, Xinlong Liu, Yang Yu, Seongdong Jeong, Yifan Ma, Annette Wu, Betty Y. S. Kim, Wen Jiang, Zhaogang Yang, Chong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-58746-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transmembrane DomainDependent Functional Oligomerization of Syndecans
by: Jae Youn Yi, et al.
Published: (2006-01-01) -
Domain swapping in allosteric modulation of DNA specificity.
by: Chad K Park, et al.
Published: (2010-12-01) -
Allosteric Lever: Toward a Principle of Specific Allosteric Response
by: Maximilian Vossel, et al.
Published: (2025-06-01) -
Entry Inhibitors of SARS-CoV-2 Targeting the Transmembrane Domain of the Spike Protein
by: Kristin V. Lyles, et al.
Published: (2025-07-01) -
Allosteric Inhibitors of Cell-Cycle-Regulated Methyltransferase for Novel Antibiotic Development
by: Ivan Hernandez, et al.
Published: (2025-04-01)